Program
Indication
Target
Discovery
Preclinical
IND-enabling
Phase 1
Phase 2
Phase 3
Collaborator
SNIPR001-Oral
Blood infections in Hema. cancers
E. coli
SNIPR001-IV
uUTI/Sepsis, Kidney transplant
MDR E. coli
SNIPR-EED
Environmental enteric dysfunction
E. coli, K. pneumoniae
SNIPR-resensitize
AMR purging
Top 9 AMR pathogens
SNIPR-lung
Chronic infections in people with CF/bronchiectasis
Pseudomonas aerguinosa
